suPAR Cut-Offs for Risk Stratification in Patients With Symptoms of COVID-19

OBJECTIVES: Elevated soluble urokinase Plasminogen Activator Receptor (suPAR) is a biomarker associated with adverse outcomes. We aimed to investigate the associations between plasma suPAR levels (testing the cut-offs ⩽4, 4-6, and ⩾6 ng/mL) with risk of 14-day mortality, and with the risk of mechani...

Descripción completa

Detalles Bibliográficos
Autores principales: Altintas, Izzet, Eugen-Olsen, Jesper, Seppälä, Santeri, Tingleff, Jens, Stauning, Marius Ahm, El Caidi, Nora Olsen, Elmajdoubi, Sanaá, Gamst-Jensen, Hejdi, Lindstrøm, Mette B, Rasmussen, Line Jee Hartmann, Kristiansen, Klaus Tjelle, Rasmussen, Christian, Nehlin, Jan O, Kallemose, Thomas, Hyppölä, Harri, Andersen, Ove
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8371731/
https://www.ncbi.nlm.nih.gov/pubmed/34421295
http://dx.doi.org/10.1177/11772719211034685

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8371731/
https://www.ncbi.nlm.nih.gov/pubmed/34421295
http://dx.doi.org/10.1177/11772719211034685

Ejemplares similares